Among other strategies, clinicians can suggest changes to lifestyle habits, encourage sleep hygiene, and prescribe pharmacologic interventions to combat risk for metabolic syndrome in shift workers.
For patients with obesity, bariatric surgery is associated with a lower long-term risk for major cardiovascular events and incident heart failure.
Machine learning identifies factors related to obesity, dyslipidemia, and inflammation as predictors of noncalcified coronary burden in patients with psoriasis, a study finds.
Increased blood glucose levels, even within the nondiabetic range, are associated with increased risk for nonalcoholic fatty liver disease.
Metformin treatment reduces some obesity measures in children.
The FDA has granted Orphan Drug designation to setmelanotide (Rhythm Pharmaceuticals) for the treatment of Alström Syndrome.
Researchers evaluated the association between blood insulin levels in adolescence and childhood and risk for asthma.
Patients with psoriasis who are naïve to biologic agents and patients who are within normal weight ranges may benefit the most from treatment with ustekinumab.
Early markers of cardiovascular and metabolic disease were elevated in adolescents with psoriasis, despite early disease.
Metabolic syndrome, including hypertension, obesity, dyslipidemia, and hyperglycemia, promote arterial stiffness, which has been linked to depression.
